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ABSTRACT Pseudomonas aeruginosa produces an extracellular bioﬁlm matrix that consists of nucleic acids, exopolysaccharides, lipid vesicles, and proteins. In general, the protein component of the bioﬁlm matrix is poorly deﬁned and understudied relative to the
other major matrix constituents. While matrix proteins have been suggested to provide
many functions to the bioﬁlm, only proteins that play a structural role have been characterized thus far. Here we identify proteins enriched in the matrix of P. aeruginosa bioﬁlms. We then focused on a candidate matrix protein, the serine protease inhibitor ecotin (PA2755). This protein is able to inhibit neutrophil elastase, a bactericidal enzyme
produced by the host immune system during P. aeruginosa bioﬁlm infections. We show
that ecotin binds to the key bioﬁlm matrix exopolysaccharide Psl and that it can inhibit
neutrophil elastase when associated with Psl. Finally, we show that ecotin protects both
planktonic and bioﬁlm P. aeruginosa cells from neutrophil elastase-mediated killing. This
may represent a novel mechanism of protection for bioﬁlms to increase their tolerance
against the innate immune response.
IMPORTANCE Proteins associated with the extracellular matrix of bacterial aggregates
called bioﬁlms have long been suggested to provide many important functions to the
community. To date, however, only proteins that provide structural roles have been described, and few matrix-associated proteins have been identiﬁed. We developed a
method to identify matrix proteins and characterized one. We show that this protein,
when associated with the bioﬁlm matrix, can inhibit a bactericidal enzyme produced by
the immune system during infection and protect bioﬁlm cells from death induced by
the enzyme. This may represent a novel mechanism of protection for bioﬁlms, further
increasing their tolerance against the immune response. Together, our results are the
ﬁrst to show a nonstructural function for a conﬁrmed matrix-interacting protein.
KEYWORDS Pseudomonas aeruginosa, bioﬁlms, extracellular matrix

P

seudomonas aeruginosa is an opportunistic pathogen that causes a variety of
chronic infections (1). Many of these chronic infections have been linked to the
bioﬁlm mode of growth. Such infections are difﬁcult to eradicate because bacteria in
bioﬁlms have a higher tolerance against antimicrobial agents than their planktonic
counterparts (2). A key feature of bioﬁlm communities is an extracellular matrix, which
surrounds the resident bacteria and is composed of extracellular DNA (eDNA), exopolysaccharides, lipid vesicles, and matrix proteins. While the three exopolysaccharides of
the P. aeruginosa bioﬁlm matrix (Psl, Pel, and alginate) (3) have been fairly well studied,
our knowledge of the matrix proteins and their roles in the community is very limited
as such studies are technically challenging.
While global proteomic approaches have been used to study P. aeruginosa bioﬁlms
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(4), most studies do not distinguish between proteins derived directly from resident
cells in the bioﬁlm and proteins found in the extracellular matrix environment. Many of
these studies have characterized the proteins in the total bioﬁlm (cellular and matrix
proteins), while others have identiﬁed the proteins in the matrix once the cells have
been removed. Since the latter requires excessive processing of the bioﬁlm community
in order to isolate the matrix proteins from the cells, it is likely that some cells lyse
during the processing, leading to contamination by cellular proteins.
To date, studies of matrix proteins have focused primarily on the proteins that
provide structural support to the bioﬁlm, such as adhesins, nucleoid-associated proteins, and amyloid proteins (5). However, several exciting roles that extend beyond
promoting structural integrity for matrix proteins have been proposed (6). Biochemical
activities are found in the matrices of environmental bioﬁlms (7), suggesting that
biochemically active matrix proteins may be providing important functions for the
community. However, examples of nonstructural proteins that are active while bound
to the bioﬁlm matrix are essentially lacking in the literature. Interestingly, there is
precedence supporting this possibility in eukaryotic biology, where proteins in the
basement membrane have been shown to carry out a multitude of functions (8).
In this study, we identiﬁed 60 matrix-associated proteins using a noninvasive
proteomic approach. We hypothesized that the extracellular matrix selectively retains
biochemically active proteins that aid in the protection of the bioﬁlm. We predict that
19 of the 60 proteins have protective functions. We focused on one candidate matrix
protein, ecotin (PA2755), a serine protease inhibitor (9). This protein is of interest
because of its ability to inhibit neutrophil elastase, an enzyme produced by the innate
immune system during P. aeruginosa respiratory infections (10). During bioﬁlm growth,
ecotin levels within the extracellular matrix were found to increase over time. We show
that ecotin binds to the bioﬁlm exopolysaccharide Psl and that it inhibits neutrophil
elastase when bound to a Psl matrix in a cell-free system. Finally, we show that ecotin
can protect both planktonic and bioﬁlm P. aeruginosa cells from neutrophil elastasemediated cell death. Collectively, these results suggest that the P. aeruginosa bioﬁlm
matrix binds to and retains speciﬁc proteins that remain active in the extracellular
environment, thereby protecting the bioﬁlm community.
RESULTS
Identiﬁcation of proteins enriched in the bioﬁlm matrix. To identify proteins
enriched in the bioﬁlm matrix of P. aeruginosa, we modiﬁed a protocol used by Absalon
and colleagues in Vibrio cholerae (11). Brieﬂy, the extracellular proteins of mature
P. aeruginosa PAO1 bioﬁlms were biotinylated prior to bioﬁlm disruption. The biotinylated proteins were then puriﬁed and identiﬁed using quantitative mass spectrometry.
This “extracellular matrix proteome” was compared to the proteome of the total
bioﬁlm, in which the cells in the bioﬁlm were lysed prior to the biotinylation of the
proteins. In comparison to the extracellular matrix proteome, the “total bioﬁlm proteome” contains both intracellular and extracellular proteins. Therefore, matrix proteins
will be higher in abundance in the extracellular matrix proteome than in the total
bioﬁlm proteome. For a negative control, this analysis was also performed in the
absence of the biotinylation agent for both the extracellular matrix and total bioﬁlm
proteomes.
This analysis was conducted twice, and a total of 857 unique proteins were identiﬁed in both runs (Fig. 1). The candidate matrix proteins were identiﬁed on the basis of
the following criteria: (i) the candidate matrix proteins had greater than or equal to
two-fold spectrum counts in the extracellular bioﬁlm proteome relative to the total
bioﬁlm proteome analysis; (ii) the candidate proteins had at least 10 spectrum counts
in the extracellular bioﬁlm proteome; and (iii) the candidate proteins had greater than
or equal to two-fold spectrum counts in the biotinylated extracellular bioﬁlm proteome
relative to the bioﬁlm proteome without biotinylation. By comparing the proteomes
using these high-stringency criteria, we identiﬁed 60 proteins that are enriched in the
bioﬁlm matrix in both analyses (Fig. 1; see Tables S1 and S2 in the supplemental
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FIG 1 Proteomic analysis of the P. aeruginosa bioﬁlm matrix. Using quantitative mass spectrometry, the
extracellular matrix proteome of mature P. aeruginosa bioﬁlms was compared with the total matrix
proteome. The spectrum counts of each protein identiﬁed in two separate runs of this analysis were
compared (857 total proteins; small black circles). The candidate matrix proteins are shown in gray
squares (60 total proteins). The yellow diamonds denote proteins that we predict are involved in the
protection of the bioﬁlm (19 of the 60 total proteins).

material). On the basis of their predicted biochemical activities, we categorized 19 of
the 60 proteins as potentially playing a role in the protection of the bioﬁlm matrix
(Fig. 1 and Table S1). Of these 19 proteins, 12 have predicted oxidoreductase activity
based on the InterProScan software package (12), and another four proteins may play
a role in redox processes. Of the remaining three proteins predicted to play a role in the
protection of the bioﬁlm matrix, two have functions in facilitating protein folding, and
one is a serine protease inhibitor, which we chose to further investigate. It is important
to note that our classiﬁcation of these proteins as potentially playing a protective role
in the bioﬁlm matrix has not been veriﬁed, and it is possible that these proteins provide
other functions in the matrix.
Ecotin is a candidate matrix protein. To validate our proteomic analysis, we
focused on ecotin, a serine protease inhibitor (9) that is encoded by PA2755 (referred
to herein as eco). Ecotin was enriched approximately four-fold in the matrix proteome
(Table S1). Originally identiﬁed in Escherichia coli, ecotin inhibits enzymes, such as
trypsin, chymotrypsin, and neutrophil elastase (9). While found in a wide variety of
Gammaproteobacteria, most bacteria, including P. aeruginosa, that carry an eco gene do
not produce proteases of the class that ecotin inhibits, which suggests that ecotin does
not inhibit a bacterium’s own proteases (13, 14). Instead, it has been suggested that
ecotin may protect bacteria from external proteolytic attack in metazoan hosts. Supporting this hypothesis, ecotin in E. coli can protect against neutrophil elastasemediated cell death in vitro (15). Furthermore, ecotin and ecotin-like proteins have
been shown to be important for the virulence of Burkholderia pseudomallei (13) and the
infectivity of Leishmania major (16). We, therefore, hypothesized that ecotin in the
bioﬁlm matrix may protect P. aeruginosa bioﬁlms against proteases such as neutrophil
elastase, an enzyme the bacteria commonly come into contact with during chronic
bioﬁlm-based infections (10) via the following two mechanisms: (i) ecotin may protect
proteins in the matrix from proteolytic degradation by neutrophil elastase, and (ii)
ecotin may protect bioﬁlm cells from neutrophil elastase-mediated death. Both possibilities would help preserve bioﬁlm integrity and are not mutually exclusive.
Ecotin is found to accumulate within the extracellular matrix of mature bioﬁlms. Since P. aeruginosa has been shown to have strain-to-strain differences in its
production of bioﬁlm matrix components (17), we examined ecotin expression in a
subset of the sequenced P. aeruginosa strains in the Pseudomonas Genome Database,
all of which contain an eco gene (18) and are able to produce the P. aeruginosa
exopolysaccharides Psl and Pel (17). Via immunoblotting, we found that ecotin is
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FIG 2 Ecotin accumulates within the extracellular matrix of mature bioﬁlms. Bioﬁlms were prepared
similarly to bioﬁlms prepared for the proteomic analysis and harvested at the indicated time points. (A)
An immunoblot (IB) of ecotin in the total bioﬁlm and the extracellular matrix at different points in bioﬁlm
development. (B) The corresponding immunoblot of the matrix-associated Psl of the samples in panel A.
The two leftmost lanes are a positive control (Pos ctrl) and negative control (Neg ctrl).

expressed in all nine of the tested clinical and environmental isolates. In stationary
phase, the expression levels for these strains were at a level similar to that of our
laboratory PAO1 reference strain (Fig. S1).
Next, we determined whether ecotin expression or its presence in the bioﬁlm matrix
changes during the course of bioﬁlm growth. Using a culturing methodology similar to
that used in the proteomic analysis, we used immunoblotting to test for the presence
of ecotin in the total bioﬁlm and the extracellular matrix of bioﬁlms grown for 48, 96,
and 144 h. While ecotin is present at approximately equal levels in the total harvested
bioﬁlm biomass at all three time points of development, it was found in the extracellular matrix at high levels only in the older 144-h bioﬁlms (Fig. 2A). This increase in
ecotin in the extracellular matrix was associated with a corresponding increase in the
amounts of matrix-associated Psl exopolysaccharide (Fig. 2B).
Ecotin binds to the bioﬁlm exopolysaccharide Psl. Because the accumulation of
ecotin in the matrix was temporally associated with the accumulation of Psl (Fig. 2), we
speculated that ecotin interacts with Psl. To test this hypothesis, we used a coimmunoprecipitation method previously described to identify CdrA as a Psl-binding protein
(19). Using anti-Psl antibody-coated beads, we precipitated Psl and any interacting
proteins from cell-free supernatants of eco-overexpressing strains with wild-type or psl
mutant backgrounds. Ecotin was then detected by immunoblotting. Ecotin coprecipitated with anti-Psl antibodies in the presence, but not in the absence, of Psl (Fig. 3). For
a negative control, we examined whether another protein when overexpressed would
coimmunoprecipitate with Psl. While Tse1, an effector of the type VI secretion system
(20), was expressed, it did not precipitate with anti-Psl antibodies even in the presence
of Psl (Fig. 3). In addition, using the proteomic analysis that identiﬁed ecotin as a
matrix-interacting protein, we failed to identify ecotin as a protein enriched in the
matrix of a bioﬁlm lacking Psl. In the two separate runs, only nine and two spectral
counts were obtained for ecotin in the biotinylated extracellular bioﬁlm proteome of a
Psl-negative bioﬁlm. Since these counts are below our threshold of 10 counts, ecotin
was eliminated from further analysis of matrix-enriched proteins for the Psl-negative
bioﬁlm. Together, these results conﬁrm that ecotin binds to the bioﬁlm matrix via the
exopolysaccharide Psl and validates our screening methodology for matrix proteins.
Matrix-associated ecotin can inhibit neutrophil elastase activity. Since a protein
may lose its functionality outside the cell when interacting with the matrix, we sought
to determine whether matrix-bound ecotin is functionally active in a cell-free system.
To obtain matrix-bound ecotin, we immunoprecipitated Psl from cell-free supernatants
of cells that were overproducing both ecotin and Psl. As a control, Psl was immunoMarch/April 2018 Volume 9 Issue 2 e00543-18
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FIG 3 Ecotin binds to the exopolysaccharide Psl. Psl was immunoprecipitated from cell-free supernatants of stationary-phase cultures with anti-Psl antibodies, and coprecipitating proteins were eluted and
detected by immunoblotting. For ecotin, the supernatants were from strains overexpressing ecotin in
wild-type (⫹) or psl mutant (⫺) backgrounds. For Tse1, the supernatant was from a ΔretS mutant strain.
Input and Psl immunoprecipitation (IP: Psl) are shown. (A) Immunoblots (IB) for ecotin and Tse1. (B) The
corresponding Psl immunoblot of the samples in panel A.

precipitated from cell-free supernatants of Δeco cells that were overproducing only Psl.
The activity of neutrophil elastase was then tested in the presence of ecotin-bound or
ecotin-free matrix material. With the ecotin-bound matrix, neutrophil elastase activity
was inhibited 52.1% ⫾ 10.2% (mean ⫾ standard deviation [SD]; n ⫽ 5; P ⬍ 0.01)
compared to that with the ecotin-free matrix (Fig. 4A). This partial inhibition is likely due
to experimental technicalities: the immunoprecipitated ecotin-bound matrix contained
only 16.5 ⫾ 3.2 nM ecotin (n ⫽ 3) compared to the 100 nM neutrophil elastase added
to the experiment. Furthermore, this inhibition is likely not due to the release of ecotin
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FIG 4 Matrix-bound ecotin inhibits neutrophil elastase. Psl was immunoprecipitated (IP) from supernatants obtained from cells overexpressing either Psl alone (Δeco; PBAD-psl) or both Psl and ecotin (Δeco;
PBAD-psl; PBAD-eco). Human neutrophil elastase and a ﬂuorogenic substrate were added. Enzymatic activity
was monitored via cleavage of the substrate. (A) Elastase activity in the presence of ecotin-free and
ecotin-bound matrix material. Elastase activity is shown in the change in arbitrary units (ΔAU) per change
in time (in minutes). The error bars show 1 standard error of the mean (SEM) (n ⫽ 5). Values that are
signiﬁcantly different (P ⬍ 0.01) by Student’s t test are indicated by the bar and asterisk. (B) Immunoblot
of ecotin before and after the elastase activity assay in panel A. Samples contained either ecotin-free
matrix or ecotin-bound matrix. IN, input for immunoprecipitation; IP, immunoprecipitated matrix
material.
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FIG 5 Ecotin protects planktonic P. aeruginosa cells from neutrophil elastase-mediated killing. Planktonic
cells were grown to stationary phase (OD600 of ~2.0) and then treated with neutrophil elastase for 2 h
before cell viability was determined for wild-type (WT) cells, cells lacking ecotin (Δeco), and Δeco cells
complemented ectopically with ecotin (Δeco ⫹ eco). Log-transformed CFU/ml after treatment was
subtracted from the value before treatment to obtain the log kill. Positive numbers represent cell death,
and negative numbers represent cell growth. Error bars show 1 SEM (n ⫽ 3). Values that are signiﬁcantly
different (P ⬍ 0.01) by analysis of variance (ANOVA) with a posthoc Tukey test are indicated by a bar and
asterisk.

from the matrix, since approximately equal amounts of ecotin were bound to the
matrix before and after the elastase activity assay by immunoblotting (Fig. 4B). Nonetheless, these results show that matrix-associated ecotin can inhibit neutrophil elastase,
suggesting that ecotin in the bioﬁlm matrix can protect other matrix proteins from
proteolytic degradation.
Ecotin can protect planktonic P. aeruginosa from neutrophil elastase-mediated
killing. Since ecotin has previously been shown to protect planktonic E. coli from
neutrophil elastase-mediated killing (15), we looked at whether ecotin could protect
P. aeruginosa planktonic and bioﬁlm cells from neutrophil elastase. Using planktonic
cells, we compared the effect of neutrophil elastase treatment on the viability of
wild-type versus Δeco cells (Fig. 5). While wild-type cells decreased in viability when
treated with neutrophil elastase (a decrease of 0.93 ⫾ 0.14 log10-transformed CFU/ml
[mean ⫾ SD]; n ⫽ 3), Δeco cells had signiﬁcantly more cell death (a loss of 2.47 ⫾ 0.25
log10-transformed CFU/ml; n ⫽ 3; P ⬍ 0.01). This difference in viability is due to
neutrophil elastase, since wild-type and Δeco cells grew to similar levels in the absence
of neutrophil elastase (Fig. 5). Furthermore, this defect in Δeco cells could be rescued
by complementing the strain with an ectopic copy of eco driven under its native
promoter. When treated with neutrophil elastase, the complemented strain had a
decrease in viability that was indistinguishable from that of wild-type cells (a decrease
of 1.48 ⫾ 0.47 log10-transformed CFU/ml; n ⫽ 3; P ⫽ 0.10).
Ecotin can protect P. aeruginosa in a bioﬁlm from neutrophil elastase-mediated
killing. While our data (Fig. 4 and 5) support our hypothesis that ecotin in the bioﬁlm
matrix can protect the bioﬁlm against neutrophil elastase, to more directly test this
hypothesis, we treated static glass-grown bioﬁlms with neutrophil elastase and determined the percentage of cells killed by the treatment based on viability (propidium
iodide) staining. As expected, we saw that indeed Δeco bioﬁlms were more susceptible
to killing by neutrophil elastase than wild-type bioﬁlms were (Fig. 6A). In the absence
of neutrophil elastase treatment, Δeco bioﬁlms had an equivalent number of dead cells
as that in wild-type bioﬁlms (P ⫽ 0.57; n ⫽ 3). In comparison, after neutrophil elastase
treatment, Δeco bioﬁlms had signiﬁcantly more cell death than wild-type bioﬁlms did
(P ⬍ 0.01; n ⫽ 3). Furthermore, complementation of eco rescued the bioﬁlm susceptibility defect (P ⫽ 0.70; n ⫽ 3). These results show that ecotin can protect the bioﬁlm
from neutrophil elastase-mediated killing. This experiment, however, does not separate
the contribution of the cellular ecotin in the periplasm from that of the extracellular
matrix-bound ecotin.
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FIG 6 Ecotin protects P. aeruginosa bioﬁlm cells from neutrophil elastase-mediated killing. (A) Static
bioﬁlms of the wild-type (WT) strain, Δeco mutant, and Δeco mutant complemented with ecotin (Δeco ⫹
eco) were grown on glass slides for 20 h and then treated with neutrophil elastase for 30 m. (B) The
indicated bioﬁlms were exposed to recombinant ecotin (rEco) for 15 min and then rinsed before elastase
treatment. The adherent biomass was then stained with Syto9 to visualize the living cells (green) and
propidium iodide to visualize the dead cells (magenta). Representative images are shown with the
percentage of cells that are dead ⫾ 1 SEM (n ⫽ 3). Bars, 25 m.

To isolate the contribution of the extracellular matrix-bound ecotin, we examined
whether exogenous addition of ecotin can protect Δeco bioﬁlms from neutrophil
elastase-mediated cell death (Fig. 6B). We ﬁrst puriﬁed recombinant ecotin and conﬁrmed that this protein was capable of inhibiting neutrophil elastase in vitro (Fig. S2),
similar to that previously seen by Eggers and colleagues (15). We then tested the ability
of this protein to rescue neutrophil elastase-mediated killing of the Δeco bioﬁlm by
exposing the bioﬁlms to this recombinant ecotin and then rinsing the bioﬁlms to
remove any ecotin that did not bind to the matrix before neutrophil elastase treatment.
After neutrophil elastase treatment, Δeco bioﬁlms exposed to recombinant ecotin had
signiﬁcantly fewer dead cells compared to Δeco bioﬁlms not exposed to recombinant
ecotin (P ⬍ 0.05; n ⫽ 3) and had an equivalent number of dead cells to that of Δeco
bioﬁlms that were not treated with neutrophil elastase (P ⫽ 0.90; n ⫽ 3). This rescue of
neutrophil elastase-mediated cell death in Δeco bioﬁlms via the addition of recombinant ecotin is dependent on Psl. Unlike Δeco bioﬁlms, bioﬁlms of a mutant strain that
lack both ecotin and Psl production (Δeco ΔpslD mutant) that were exposed to
recombinant ecotin had signiﬁcantly more cell death after neutrophil elastase treatment compared to bioﬁlms not exposed to neutrophil elastase (P ⬍ 0.05; n ⫽ 3).
Therefore, Psl is required for the supplemented ecotin to protect the bioﬁlm against
neutrophil elastase-mediated cell death. This requirement for Psl is likely only for the
extracellular portion, and not the periplasmic cellular portion, of ecotin in wild-type
P. aeruginosa bioﬁlms, since endogenous cellular ecotin in other bacteria protects
against neutrophil elastase independent of Psl. These results further support our
March/April 2018 Volume 9 Issue 2 e00543-18

mbio.asm.org 7

Downloaded from mbio.asm.org on May 22, 2018 - Published by mbio.asm.org

®

Ecotin Protects Bioﬁlms from Protease Attack

®

conclusion that ecotin is a Psl-interacting protein in the bioﬁlm matrix and that
matrix-associated ecotin is functional. Together, our results show that ecotin in the
matrix can protect not only other matrix proteins but also bioﬁlm cells from proteolytic
attack.
DISCUSSION
While matrix proteins have been suggested to provide several nonstructural functions to the bioﬁlm community (6), examples of such proteins in the literature are very
limited. We, therefore, undertook a proteomic approach to identify matrix proteins in
P. aeruginosa bioﬁlms (Fig. 1; also see Table S1 in the supplemental material). As a proof
of principle, we characterized one candidate matrix protein, ecotin. This protein was of
interest because it inhibits neutrophil elastase, a bactericidal enzyme produced by the
innate immune system during P. aeruginosa respiratory infections. Our data strongly
suggest that this matrix protein is active when bound to the exopolysaccharide Psl
(Fig. 4A and 6), and our data show that it can protect P. aeruginosa in a bioﬁlm from
neutrophil elastase-mediated killing (Fig. 6). While recombinant ecotin has been previously shown to inhibit neutrophil elastase (15), our data strongly suggest that not
only does the endogenous P. aeruginosa ecotin inhibit neutrophil elastase but that it
does so when bound to the bioﬁlm matrix. This is not an inherently obvious result, as
binding to the matrix, or any other molecule, could have impaired ecotin function. We
propose that matrix-associated proteins play a crucial role in bioﬁlm-mediated resistance to host defenses.
The major advantage of our proteomic approach is its selectivity. First, bioﬁlms were
grown under continuous ﬂow. Since cell lysis is a natural part of bioﬁlm formation, the
ﬂow allows proteins that do not interact with the matrix to be continuously washed
away. This ﬂow-based growth method is, therefore, more stringent for identifying
matrix-interacting proteins than the static methods for bioﬁlm growth that have been
used in the past, in which a limited number of washes are used to remove noninteracting proteins (21–23). Second, for the extracellular matrix proteome, the proteins in
the bioﬁlm matrix are labeled prior to mechanical/physical disruption of the system,
limiting the effects of experimentally introduced cell lysis and greatly reducing the
probability of cellular protein contamination. Third, the extracellular matrix proteome is
compared to the total bioﬁlm proteome at the same point in bioﬁlm development,
eliminating the effects of general proteome changes that are known to occur over
bioﬁlm development (24). It should be noted, however, that we have conﬁrmed only
one protein, ecotin, in our list of candidates (Table S1) as a bona ﬁde matrix-interacting
protein. While outside the scope of this work, the other candidates still need to be
individually veriﬁed.
Our list of 60 candidate matrix proteins is likely far from exhaustive. As a control,
abundant intracellular proteins that are not expected to be in the matrix, such as
subunits of RNA polymerase, were identiﬁed in the total bioﬁlm proteome, but not in
the extracellular matrix proteome. However, due to the high-stringency criteria and
comparison approach used, the number of false-negative results is likely high. For
instance, proteins that are high in abundance in the cell, such as nucleoid-associated
proteins (25), or that are identiﬁed in the sample without the biotinylation agent, such
as ﬂagellin, were eliminated as potential candidates. Furthermore, our puriﬁcation
method likely selected against proteins in outer membrane vesicles (OMVs), as we saw
only ﬁve such proteins of the 60 proteins identiﬁed (Table S2). These results are in
contrast to previously published work for P. aeruginosa (21, 23), in which larger
percentages of outer membrane proteins were identiﬁed. However, the many differences in the methodologies used likely explain this discrepancy. For instance, since our
study involved more puriﬁcation steps, outer membrane-associated proteins, especially
adhesins such as LecA (26), LecB (27), and CdrA (19), may have been selected against,
hence the lower percentage of these proteins in our data set.
A majority of the candidate matrix proteins we identiﬁed, including ecotin, are not
predicted to be exported outside the cell (Table S2). It is unclear whether these proteins
March/April 2018 Volume 9 Issue 2 e00543-18
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become extracellular through nonclassical protein secretion mechanisms (28) or via cell
lysis, which is a natural part of bioﬁlm formation (29). Independently of how these
proteins become extracellular, we hypothesize that matrix proteins are selectively
retained by the bioﬁlm via their interaction with structural matrix polymers (e.g., eDNA,
polysaccharides, and amyloid proteins) and that non-matrix-interacting proteins are
lost to the environment via diffusion. Supporting this hypothesis, our data show that
ecotin binds to Psl both in a cell-free system (Fig. 3A) and in the bioﬁlm (Fig. 6B).
Furthermore, we would expect that the presence of any speciﬁc matrix protein should
temporally correlate with the presence of its interacting structural matrix component,
which we also see for ecotin and Psl (Fig. 2).
While very different ﬁelds, there are parallels between the basement membrane of
metazoans and the bacterial extracellular bioﬁlm matrix. Similar to the bioﬁlm matrix,
the basement membrane was once considered to be simply a passive scaffold for
polarized epithelial cell attachment, but the basement membrane has become a major
area of study due to its many roles and associations with human disease (8). While both
matrices clearly provide structural support to the cells interacting with them, the
interaction of cells with speciﬁc components of both matrices also leads to complex
signaling within the cells (30, 31). While speculative, it is tempting to draw other
parallels. For instance, enzymes within the basement membrane that remodel the
matrix are important for proper tissue development (32, 33). This may also be true for
bioﬁlms and the predicted enzymatic matrix proteins that we identiﬁed. Additionally,
the basement membrane contains matrix components that when processed can protect the host (34–36), similar to how ecotin and other matrix proteins may be protecting
the bioﬁlm.
Components of the bioﬁlm matrix are known to protect the resident bacteria against
the host innate immune response (37). For instance, eDNA increases the resistance of
P. aeruginosa against the cationic antimicrobial peptides secreted by leukocytes (38),
and the P. aeruginosa exopolysaccharides alginate and Psl inhibit phagocytosis by
neutrophils and macrophages (39–41), as well as limit complement activation (41, 42).
Adding to the repertoire of the protective mechanisms in the bioﬁlm, our results
suggest that ecotin in the bioﬁlm matrix can protect matrix proteins and the resident
cells from proteolytic attack. This is a novel mechanism by which the bioﬁlm may
protect itself against a key mediator of the host innate immune response. Our proteomic analysis also identiﬁed multiple proteins with oxidoreductase activity, suggesting that there may be matrix proteins that can mitigate the stress induced by the
neutrophil oxidative burst in the extracellular space of bioﬁlms. Therefore, the protective effects of P. aeruginosa bioﬁlms against the innate immune response via its matrix
are potentially multifaceted and likely more complicated than currently envisioned.
MATERIALS AND METHODS
Full, detailed descriptions of all the methods used are described in Text S1 in the supplemental
material.
Bacterial strains, growth conditions, and antibiotics. The bacterial strains, plasmids, and primers
used in this study are listed in Tables S3 to S5, respectively. Construction of the strains used in this study
are described in Text S1. Unless otherwise noted, bacteria were grown at 37°C in lysogeny broth (LB) or
in Vogel-Bonner minimal medium (43).
Antibodies and immunoblots. Primary antibodies were diluted in 5% milk in phosphate-buffered
saline (PBS) with 0.05% Tween 20: anti-ecotin sera (raised against AKLDEKVPYPKADC; Covance) diluted
1/400, anti-Psl antibodies (MedImmune) (44) diluted 1/3,000, and anti-Tse1 antibodies (20) diluted
1/2,000. Psl immunoblotting was performed as previously described (45). For SDS-PAGE, proteins were
separated on an 18% Tris HCl gel and transferred to nitrocellulose for immunoblotting.
Identiﬁcation of proteins enriched in the matrix. Tube bioﬁlms were grown as previously
described (46) in amine-free medium [60 mM trisodium citrate, 15 mM K2HPO4, 50 mM (NH4)2SO4,
1.33 mM MgSO4, 140 M CaCl2, 8.5 M ZnSO4, 3.9 M FeSO4, pH 7.5] for 6 days at 25°C. For the total
bioﬁlm proteome analysis, the cells in the bioﬁlm biomass were ﬁrst lysed before the proteins in the
sample were biotinylated. For the extracellular bioﬁlm proteome, the extracellular proteins in the bioﬁlm
were biotinylated before the biomass was collected and the cells were removed from the matrix material.
The biotinylated proteins were puriﬁed and digested with trypsin. The resulting peptides were then
identiﬁed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
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Psl coimmunoprecipitation. Psl coimmunoprecipitations were performed as previously described
with the following modiﬁcations (19). Brieﬂy, anti-Psl antibodies (MedImmune)-conjugated magnetic
protein A Dynabeads (Life Technologies) were incubated with cell-free supernatants from stationaryphase cultures. Proteins coprecipitating with Psl were eluted with Laemmli buffer and analyzed by
immunoblotting.
Ecotin expression proﬁling. For planktonic expression experiments, cells were resuspended in
Laemmli buffer at 1010 CFU/ml and analyzed by immunoblotting. To determine when ecotin is associated
with the bioﬁlm matrix, tube bioﬁlms were grown as described above to the desired time point. Half of
the sample was lyophilized to obtain the dry weight. In the other half of the sample, the cells were
removed from the matrix. The proteins in the supernatant were normalized based on their dry weight
measurements and analyzed by SDS-PAGE.
Neutrophil elastase inhibition assay. Psl was precipitated on the magnetic beads as described
above, and neutrophil elastase (Millipore) at 100 nM and the ﬂuorogenic substrate (MeOSucAAPV-AMC;
Millipore) at 0.25 mM were then added. Cleavage of the substrate was measured at an excitation
wavelength of 380 nm and an emission wavelength of 460 nm (Ex380/Em460). After the experiment, the
beads were recovered, and the proteins were analyzed by SDS-PAGE as described above.
Neutrophil elastase killing assay. For planktonic experiments, cells at an OD600 of ~2.0 were treated
with neutrophil elastase (Oxford Biomedical Research) at 250 g/ml at 37°C for 2 h before viable-cell
counts were determined. For bioﬁlm experiments, bioﬁlms grown for 20 h on glass slides were treated
with 100 M ecotin and 2 M neutrophil elastase (Millipore) for 30 min. The biomass was stained with
5 M Syto9 (Molecular Probes) and 30 M propidium iodide (Sigma-Aldrich) for 15 min before imaging
with a Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss).

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00543-18.
TEXT S1, PDF ﬁle, 0.1 MB.
FIG S1, PDF ﬁle, 0.1 MB.
FIG S2, PDF ﬁle, 0.1 MB.
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TABLE S2, PDF ﬁle, 0.04 MB.
TABLE S3, PDF ﬁle, 0.04 MB.
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